DK0683167T3 - Terazosin monohydrochlorid og fremgangsmåder og mellemprodukter til dets fremstilling - Google Patents

Terazosin monohydrochlorid og fremgangsmåder og mellemprodukter til dets fremstilling

Info

Publication number
DK0683167T3
DK0683167T3 DK95103186T DK95103186T DK0683167T3 DK 0683167 T3 DK0683167 T3 DK 0683167T3 DK 95103186 T DK95103186 T DK 95103186T DK 95103186 T DK95103186 T DK 95103186T DK 0683167 T3 DK0683167 T3 DK 0683167T3
Authority
DK
Denmark
Prior art keywords
preparation
methods
terazosin monohydrochloride
intermediates
terazosin
Prior art date
Application number
DK95103186T
Other languages
English (en)
Inventor
James A Morley
John F Bauer
Ramesh R Patel
Stephen G Spanton
Rodger F Henry
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22931058&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0683167(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of DK0683167T3 publication Critical patent/DK0683167T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK95103186T 1994-05-20 1995-03-06 Terazosin monohydrochlorid og fremgangsmåder og mellemprodukter til dets fremstilling DK0683167T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/246,526 US5412095A (en) 1993-04-29 1994-05-20 Terazosin monohydrochloride and processes and intermediate for its production

Publications (1)

Publication Number Publication Date
DK0683167T3 true DK0683167T3 (da) 2000-02-07

Family

ID=22931058

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95103186T DK0683167T3 (da) 1994-05-20 1995-03-06 Terazosin monohydrochlorid og fremgangsmåder og mellemprodukter til dets fremstilling

Country Status (10)

Country Link
US (1) US5412095A (da)
EP (1) EP0683167B1 (da)
JP (1) JP2755918B2 (da)
AT (1) ATE182592T1 (da)
CA (1) CA2143974C (da)
DE (2) DE69510999T2 (da)
DK (1) DK0683167T3 (da)
ES (1) ES2093579T3 (da)
GR (2) GR960300046T1 (da)
HK (1) HK1012629A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587377A (en) * 1995-10-24 1996-12-24 Invamed, Inc. Terazosin crystalline polymorph and pharmaceutical compositions thereof
DE19546573A1 (de) * 1995-12-13 1997-06-19 Uetikon Chemie Gmbh Kristallines Polymorph von Terazosin-Hydrochlorid, sowie Verfahren zu seiner Herstellung
US5952003A (en) * 1996-08-01 1999-09-14 Novartis Corporation Terazosin capsules
IT1286790B1 (it) * 1996-11-29 1998-07-17 Alfa Chem Ital Processo per la produzione della forma i del terazosin monocloridrato anidro
IT1286789B1 (it) * 1996-11-29 1998-07-17 Alfa Chem Ital Processo per la produzione della forma i del terazosin monocloridato anidro
EP0849265A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von Doxazosin-Mesylat (Form II)
PT849266E (pt) * 1996-12-20 2007-03-30 Heumann Pcs Gmbh Nova forma polimorfa de mesilato de doxazosina (forma iii)
EP0849264A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von doxazosinmesylat (Form I)
US6248888B1 (en) 1997-11-14 2001-06-19 Teva Pharmaceutical Industries Ltd. Process for the preparation of terazosin hydrochloride dihydrate
US6200573B1 (en) 1999-12-03 2001-03-13 Starcor Pharmaceuticals, Inc. Method of medical management for lower urinary tract symptoms and benign prostatic hyperplasia
US20030068829A1 (en) * 2001-06-25 2003-04-10 Symyx Technologies, Inc. High throughput crystallographic screening of materials
TWI353979B (en) * 2002-04-10 2011-12-11 Nippon Zoki Pharmaceutical Co Novel crystal form of 5-hydroxy-1-methylhydantoin
AU2007286186A1 (en) * 2006-08-08 2008-02-21 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
GB1591490A (en) * 1977-08-04 1981-06-24 Abbott Lab 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate
DE3683760D1 (de) * 1986-03-21 1992-03-12 Heumann Pharma Gmbh & Co Kristalline, wasserfreie sigma -form von 2-(4-(2-furoyl-(2-piperazin)-1-yl)-4-amino-6,7-dimethoxychinazolinhydrochlorid und verfahren zu ihrer herstellung.
US5212176A (en) * 1990-06-29 1993-05-18 Abbott Laboratories R(+)-terazosin
JP2652272B2 (ja) * 1990-12-31 1997-09-10 住化ファインケム株式会社 １−（４−アミノ−６，７−ジメトキシ−２−キナゾリニル）−４−（２−テトラヒドロフロイル）ピペラジン塩酸塩の新規な結晶体および該結晶体の製造方法
US5294615A (en) * 1993-04-29 1994-03-15 Abbott Laboratories Terazosin polymorph and pharmaceutical composition

Also Published As

Publication number Publication date
EP0683167A1 (en) 1995-11-22
DE69510999T2 (de) 2000-02-17
CA2143974C (en) 1997-06-03
CA2143974A1 (en) 1995-11-21
DE69510999D1 (de) 1999-09-02
JPH0848685A (ja) 1996-02-20
HK1012629A1 (en) 1999-08-06
EP0683167B1 (en) 1999-07-28
ATE182592T1 (de) 1999-08-15
GR960300046T1 (en) 1996-08-31
ES2093579T3 (es) 1999-11-01
GR3031248T3 (en) 1999-12-31
ES2093579T1 (es) 1997-01-01
US5412095A (en) 1995-05-02
DE683167T1 (de) 1996-11-07
JP2755918B2 (ja) 1998-05-25

Similar Documents

Publication Publication Date Title
DK0683167T3 (da) Terazosin monohydrochlorid og fremgangsmåder og mellemprodukter til dets fremstilling
NO932870D0 (no) Ny fremgangsmaate for fremstilling av 9-amino-6-demetyl-6-deoksyetracykliner
HU9601857D0 (en) New benzyl-piperidine- or -tetrahydro-pyridine derivatives and processes for producing them
DK0535928T3 (da) Fremgangsmåde til fremstilling af mellemprodukter til anvendelse i fremstilling af alkoxyiminoacetamider
ES2162367T3 (es) Metodo de produccion de un compuesto de aminobenceno.
MXPA04000847A (es) Procedimiento para la obtencion de beraprost y sus sales.
DK1129087T3 (da) Fremgangsmåde til racemisering
ATE457972T1 (de) Verfahren zur herstellung von 7-amino-syn-3,5- dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
DK0543095T3 (da) Fremgangsmåde til fremstilling af 2-amino-6-halogenpurin og syntese af et mellemprodukt dertil
DE3851865D1 (de) Verfahren zur Umwandlung des niedrigschmelzenden Polymorphs von Buspirone hydrochlorid in das höherschmelzende.
FR2557876B1 (fr) Synthese a haute pression de melamine anhydre
DE3572969D1 (en) A novel process for the preparation of bestatin derivatives and intermediates thereof
DK0492350T3 (da) Fremgangsmåde til fremstilling af (S)-vinyl- og (S)-allenyl-GABA
NO861953L (no) Oksadiazolylimidazobenzodiazepinforbindelse og fremgangsmaate til fremstilling derav.
FI956247A (fi) Uusia menetelmiä (S)-4-amino-hepta-5,6-dieenihappo ja sen välituotteiden valmistamiseksi
WO2001092251A3 (en) Aryloxy ester and acid compounds
HU0000823D0 (en) Process for producing intermediates, which applicable at production of n-(aryl-oxy-alkyl)-heteroaryl-piperidine-and heteroaryl-piperazine derivatives